145 related articles for article (PubMed ID: 32447239)
21. Clinical factors predict surgical outcomes in pediatric MRI-negative drug-resistant epilepsy.
Arya R; Leach JL; Horn PS; Greiner HM; Gelfand M; Byars AW; Arthur TM; Tenney JR; Jain SV; Rozhkov L; Fujiwara H; Rose DF; Mangano FT; Holland KD
Seizure; 2016 Oct; 41():56-61. PubMed ID: 27474907
[TBL] [Abstract][Full Text] [Related]
22. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD001904. PubMed ID: 27976799
[TBL] [Abstract][Full Text] [Related]
23. Oxcarbazepine, an antiepileptic agent.
Kalis MM; Huff NA
Clin Ther; 2001 May; 23(5):680-700; discussion 645. PubMed ID: 11394728
[TBL] [Abstract][Full Text] [Related]
24. Antiepileptic drug reduction and increased risk of stimulation-evoked focal to bilateral tonic-clonic seizure during cortical stimulation in patients with focal epilepsy.
Hampel KG; Gómez-Ibáñez A; Garcés-Sánchez M; Hervás-Marín D; Cano-López I; González-Bono E; Conde-Sardón R; Gutiérrez-Martín A; Villanueva V
Epilepsy Behav; 2018 Mar; 80():104-108. PubMed ID: 29414538
[TBL] [Abstract][Full Text] [Related]
25. Multivariable prediction model of drug resistance in adult patients with generalized epilepsy from Colombia: A case-control study.
Orozco-Hernández JP; Quintero-Moreno JF; Marín-Medina DS; Valencia-Vásquez A; Villada HC; Lizcano A; Martínez JW
Epilepsy Behav; 2018 Nov; 88():176-180. PubMed ID: 30290326
[TBL] [Abstract][Full Text] [Related]
26. Drug-resistant idiopathic generalized epilepsy: A meta-analysis of prevalence and risk factors.
Jiang T; Zhang X; Zhang M; Liu M; Zhu H; Sun Y
Epilepsy Behav; 2023 Sep; 146():109364. PubMed ID: 37523796
[TBL] [Abstract][Full Text] [Related]
27. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
28. Predicting seizures in pregnant women with epilepsy: Development and external validation of a prognostic model.
Allotey J; Fernandez-Felix BM; Zamora J; Moss N; Bagary M; Kelso A; Khan R; van der Post JAM; Mol BW; Pirie AM; McCorry D; Khan KS; Thangaratinam S
PLoS Med; 2019 May; 16(5):e1002802. PubMed ID: 31083654
[TBL] [Abstract][Full Text] [Related]
29. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001911. PubMed ID: 28240353
[TBL] [Abstract][Full Text] [Related]
30. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy.
Christe W; Krämer G; Vigonius U; Pohlmann H; Steinhoff BJ; Brodie MJ; Moore A
Epilepsy Res; 1997 Mar; 26(3):451-60. PubMed ID: 9127726
[TBL] [Abstract][Full Text] [Related]
31. A scale for prediction of response to AEDs in patients with MRI-negative epilepsy.
Yang SJ; He GN; Han X; Wang N; Chen Y; Zhu XR; Ma BQ; Li MM; Zhao P; Chen YN; Zhao T; Ma H
Epilepsy Behav; 2019 May; 94():41-46. PubMed ID: 30884406
[TBL] [Abstract][Full Text] [Related]
32. Oxcarbazepine: a review of its use in children with epilepsy.
Bang L; Goa K
Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
[TBL] [Abstract][Full Text] [Related]
33. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2015 Aug; (8):CD001911. PubMed ID: 26275105
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology and outcome of idiopathic generalized epilepsy in adults.
Gesche J; Christensen J; Hjalgrim H; Rubboli G; Beier CP
Eur J Neurol; 2020 Apr; 27(4):676-684. PubMed ID: 31838768
[TBL] [Abstract][Full Text] [Related]
35. How reliable is early treatment response in predicting long-term seizure outcome?
Schmidt D
Epilepsy Behav; 2007 Jun; 10(4):588-94. PubMed ID: 17418644
[TBL] [Abstract][Full Text] [Related]
36. Spotlight on oxcarbazepine in epilepsy.
Bang LM; Goa KL
CNS Drugs; 2004; 18(1):57-61. PubMed ID: 14731060
[TBL] [Abstract][Full Text] [Related]
37. Jeavons Syndrome: Clinical Features and Response to Treatment.
Smith KM; Youssef PE; Wirrell EC; Nickels KC; Payne ET; Britton JW; Shin C; Cascino GD; Patterson MC; Wong-Kisiel LC
Pediatr Neurol; 2018 Sep; 86():46-51. PubMed ID: 30082241
[TBL] [Abstract][Full Text] [Related]
38. Drug-resistant epilepsy in adults: Outcome trajectories after failure of two medications.
Choi H; Hayat MJ; Zhang R; Hirsch LJ; Bazil CW; Mendiratta A; Kato K; Javed A; Legge AW; Buchsbaum R; Resor S; Heiman GA
Epilepsia; 2016 Jul; 57(7):1152-60. PubMed ID: 27265407
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of drug resistant epilepsy in adults with epilepsy attending a neurology clinic of a tertiary referral hospital in Singapore.
Kong ST; Ho CS; Ho PC; Lim SH
Epilepsy Res; 2014 Sep; 108(7):1253-62. PubMed ID: 24910376
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and Tolerability of Lacosamide in the Treatment of Children With Refractory Generalized Epilepsy.
Miskin C; Khurana DS; Valencia I; Legido A; Hasbani DM; Carvalho KS
J Child Neurol; 2016 Jun; 31(7):925-8. PubMed ID: 26887412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
